Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

F137 - Updates in the Use of Ancillary Techniques to Diagnose, Stage, and Determine the Prognosis of Melanocytic Lesions

Monday, February 19; 1:00 PM - 3:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Diagnose difficult melanocytic lesions better through ancillary techniques.
  • Appropriately order or ask for those ancillary methodologies and explain them to the patient.

Description

The session will cover the use of ancillary methodologies in order to stage, diagnose and prognosticate melanocytic lesions. This will include but is not limited to immunohistochemistry, fluorescence in situ hybridization, comparative genomic hybridization, gene sequencing, and molecular algorithms for diagnosis and prognosis.

Disclosures

  • Phelps, Robert G., MD: sanofi-aventis – C(Fees);
  • Singh, Rajendra, MD: no financial relationships exist with commercial interests.
Schedule
Monday, February 19
1:00 PM
Dr. Phelps / Immunohistochemistry and molecular methods in diagnosis an staging
2:00 PM
Dr. Singh / Molecular algorithms and information technology in diagnosis and prognosis
Event Details
  • Date
    Monday, February 19
  • Time
    1:00 PM - 3:00 PM
  • Location
    Room 24B
  • CME Credits
    2.00
  • Type
    New
Directors/Co-Directors
  • Robert G. Phelps, MD, FAAD
Speakers
  • Rajendra Singh, MD